银屑病甲剥离患者HR-pQCT检出远端指骨骨侵蚀
该研究比较了无PsA的银屑病甲剥离患者(ONY)、仅皮肤银屑病患者(PSO)、PsA患者及健康对照的DIP关节超声肌腱厚度与HR-pQCT骨侵蚀。ONY组伸肌腱厚度显著大于PSO组,骨侵蚀频率(57% vs 14%,P<0.001)和平均侵蚀数(1.10 vs 0.03,P<0.001)均显著高于PSO组。结论认为甲剥离与附着点病变及骨侵蚀相关,可作为银屑病严重度的替代标志物。
要点
- 无PsA的银屑病甲剥离患者DIP关节骨侵蚀频率达57%,显著高于仅皮肤银屑病患者的14%。
- 甲剥离患者伸肌腱厚度显著大于仅皮肤银屑病患者,提示附着点病变。
- 甲剥离可作为银屑病严重度的替代标志物,支持附着点病变在PsA中的致病作用。
核心结论
- 甲剥离与显著的附着点病变和骨侵蚀相关,支持附着点病变在PsA中的致病作用。
- 甲剥离可被视为银屑病严重度的替代标志物。
研究设计与样本
- 比较无PsA的银屑病甲剥离患者(ONY)、仅皮肤银屑病患者(PSO)、PsA患者(PsA组)及年龄匹配健康对照(CTRL)的DIP关节超声肌腱厚度与HR-pQCT骨侵蚀。
- 共87名参与者(61%男性),平均(s.e.m.)年龄45.2(1.3)岁,组间差异采用方差分析及Scheffe事后检验。
主要发现
- ONY组伸肌腱厚度显著大于PSO组。
- PsA组68%患者存在V形、Omega形和U形三种形态的骨侵蚀。
- ONY组骨侵蚀频率为57%,PSO组为14%(P<0.001)。
- ONY组平均骨侵蚀数为1.10(0.35),PSO组为0.03(0.03)(P<0.001)。
关键数值与推荐
- 骨侵蚀频率:ONY组57% vs PSO组14%,P<0.001。
- 平均骨侵蚀数:ONY组1.10(0.35) vs PSO组0.03(0.03),P<0.001。
- PsA组68%患者存在V形、Omega形和U形骨侵蚀。
临床怎么用
- 对银屑病甲剥离患者应关注DIP关节附着点病变及早期骨侵蚀,即使无PsA症状。
- 甲剥离可作为银屑病严重度的替代标志物,提示需进一步评估关节受累。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: PsA prevalence among skin psoriasis is ∼30%. Nail psoriasis, especially onycholysis, is present in >70% of PsA and the risk of developing PsA is more than doubled in patients with nail involvement. We hypothesized that onycholysis may be associated with early bone erosions of the DIP joint without harbouring PsA symptoms. METHODS: We compared tendon thickness, assessed by US, and bone erosions, assessed by high-resolution peripheral quantitative CT, of the DIP joint in patients with psoriatic onycholysis without PsA (ONY) with those in patients with cutaneous psoriasis only (PSO). We used patients with PsA as reference (PsA group), and healthy age-matched controls (CTRL). Differences between groups were assessed by analysis of variance tests followed by post hoc analysis using the Scheffe method. RESULTS: Mean (s.e.m.) age of the 87 participants (61% males) was 45.2 (1.3) years. The mean extensor tendon thickness was significantly larger in ONY than in PSO patients. In the PsA group, 68% of patients exhibited erosions of three different shapes: V-, Omega- and U-shape. Association with erosions was greater in the ONY group than in the PSO group (frequency: 57 vs 14%; P < 0.001; mean number of erosions: 1.10 (0.35) vs 0.03 (0.03); P < 0.001). CONCLUSION: Onycholysis was associated with significant enthesopathy and bone erosions in our cohort. These data support the pathogenic role of enthesopathy in PsA. Onycholysis may be considered as a surrogate marker of severity in psoriasis. TRIAL REGISTRATION: ClinicalTrails.gov, https://clinicaltrials.gov, NCT02813720.
引用
- Villani AP, Boutroy S, Coutisson C, et al. Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis. Rheumatology (Oxford). 2021. PMID: 32885241. doi:10.1093/rheumatology/keaa415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。